FDA-cleared for pediatric use, the Vbeam Pro® combines 595 nm pulsed dye and 1064 nm Nd:YAG lasers to treat a wide range of skin conditions across all skin types. ...
Procedure is designed to fragment kidney stones using low pressure ultrasound waves in fully awake patients, without anesthesia, in the office or clinic ...
The new HF-index enables accurate, on-demand heart failure severity tracking using single-lead ECG data from wearable devices....
First-of-Its-Kind, FDA-Approved, Needle-Free, Portable Radio Frequency Device Now Available in the U.S. Market ...
Innovative endovascular treatment for communicating hydrocephalus gains regulatory support for patients aged 12 and older....
FINDER® platform enables rapid, low-volume Anti-Factor Xa testing, transforming anticoagulation care at the bedside....
The regulatory milestone paves the way for broader adoption of its neuroimaging solutions across North America....
Single-use, 2-channel wearable Biosensor, patient-facing app and cloud-based system enable final Holter reports in hours—not days. ...
The policy expands access to this effective, non-drug treatment for members as young as 8 years old who are diagnosed with migraine ...
The FDA has granted authorisation for Minder under its De Novo pathway creating a new classification of device, allowing for marketing and sale of the device in the US for patients with drug resistant epilepsy...
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
